BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 23, 2008
View Archived Issues
Resolvyx Adds $25M to Move First Resolvin Drugs into Clinic
Gearing up to move its first two drug candidates into the clinic this year, Resolvyx Pharmaceuticals Inc. padded its bank account with a $25 million Series B round from new and existing investors. (BioWorld Today)
Read More
Congress Told Foreign Plants are 'Ticking Time Bombs'
Read More
'Pseudokinase' Found Active, Without Binding Magnesium
Read More
CuraGen Sells Cancer Drug to TopoTarget for $45M
Read More
Genzyme Must File 2 BLAs for Myozyme Formulations
Read More
Theravance Cuts Staff 40%; Telavancin Inches Along
Read More
FDA Approves Cimzia for Crohn's Disease
Read More
Spectrum Shares Falls on Ozarelix Miss
Read More
ImClone, BioVex Secure SPAs For Late-Stage Cancer Studies
Read More
Other News To Note
Read More
Clinic Roundup
Read More